Bladder oxybutynin for children with spina bifida
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a liquid form of the medication oxybutynin placed directly into the bladder (via catheter) for children with spina bifida who have bladder overactivity. It may be an option if oral medications haven't worked well or caused side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 6 and 17 years old
- Has spina bifida with an overactive bladder confirmed by a recent urodynamic test
- Uses a catheter to empty the bladder at least 3 times a day for at least 6 weeks
- Previous oral bladder medications either didn't work well or caused intolerable side effects
- Willing and able to perform bladder instillation (medicine put directly into the bladder via catheter) either by the child or a parent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether biofeedback training (a technique that uses sensors to help your child learn to control their bladder and bowel muscles) can improve bladder and bowel function in children with spina bifida. It might help your child gain more control over these functions.
This study tests whether stimulating a nerve in the leg (the tibial nerve) with a small device can help children with spina bifida who leak urine even when using a catheter. The treatment is non-invasive, like a tiny electrical patch near the ankle, and aims to improve bladder control.
This trial tests an enema device to help children and young adults with spina bifida better manage bowel leaks. If you already do regular enemas, the study will see whether the device makes bowel care easier and more effective.
This trial studies blood vessels in people with spina bifida using safe, non-invasive methods. It aims to better understand how the condition affects the body over time.
This trial tests whether early use of oxybutynin can improve bladder and urine behavior in very young boys with posterior urethral valves. It is mainly for babies whose bladder tests show problems even after valve surgery.
This trial compares two treatments for kids with overactive bladder: oxybutynin medicine and a painless nerve stimulation device. It aims to find which works better for reducing frequent, urgent, or leaky urination and nighttime accidents.
Hear when a new Spina Bifida trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.